Role	O
of	O
SWI	O
/	O
SNF	O
in	O
acute	O
leukemia	O
maintenance	O
and	O
enhancer	O
-	O
mediated	O
Myc	O
regulation	O
.	O


Cancer	O
cells	O
frequently	O
depend	O
on	O
chromatin	O
regulatory	O
activities	O
to	O
maintain	O
a	O
malignant	O
phenotype	O
.	O


Here	O
,	O
we	O
show	O
that	O
leukemia	O
cells	O
require	O
the	O
mammalian	O
SWI	O
/	O
SNF	O
chromatin	O
remodeling	O
complex	O
for	O
their	O
survival	O
and	O
aberrant	O
self	O
-	O
renewal	O
potential	O
.	O


While	O
Brg1	O
,	O
an	O
ATPase	O
subunit	O
of	O
SWI	O
/	O
SNF	O
,	O
is	O
known	O
to	O
suppress	O
tumor	O
formation	O
in	O
several	O
cell	O
types	O
,	O
we	O
found	O
that	O
leukemia	O
cells	O
instead	O
rely	O
on	O
Brg1	O
to	O
support	O
their	O
oncogenic	O
transcriptional	O
program	O
,	O
which	O
includes	O
Myc	O
as	O
one	O
of	O
its	O
key	O
targets	O
.	O


To	O
account	O
for	O
this	O
context	O
-	O
specific	O
function	O
,	O
we	O
identify	O
a	O
cluster	B-ENHANCER
of	I-ENHANCER
lineage	I-ENHANCER
-	I-ENHANCER
specific	I-ENHANCER
enhancers	I-ENHANCER
located	I-ENHANCER
1	I-ENHANCER
.	I-ENHANCER
7	I-ENHANCER
Mb	I-ENHANCER
downstream	I-ENHANCER
from	I-ENHANCER
Myc	E-ENHANCER
that	O
are	O
occupied	O
by	O
SWI	O
/	O
SNF	O
as	O
well	O
as	O
the	O
BET	O
protein	O
Brd4	O
.	O


Brg1	O
is	O
required	O
at	O
these	O
distal	B-ENHANCER
elements	E-ENHANCER
to	O
maintain	O
transcription	O
factor	O
occupancy	O
and	O
for	O
long	O
-	O
range	O
chromatin	O
looping	O
interactions	O
with	O
the	O
Myc	O
promoter	O
.	O


Notably	O
,	O
these	O
distal	B-ENHANCER
Myc	I-ENHANCER
enhancers	E-ENHANCER
coincide	O
with	O
a	O
region	O
that	O
is	O
focally	O
amplified	O
in	O
~	O
3	O
%	O
of	O
acute	O
myeloid	O
leukemias	O
.	O


Together	O
,	O
these	O
findings	O
define	O
a	O
leukemia	O
maintenance	O
function	O
for	O
SWI	O
/	O
SNF	O
that	O
is	O
linked	O
to	O
enhancer	O
-	O
mediated	O
gene	O
regulation	O
,	O
providing	O
general	O
insights	O
into	O
how	O
cancer	O
cells	O
exploit	O
transcriptional	O
coactivators	O
to	O
maintain	O
oncogenic	O
gene	O
expression	O
programs	O
.	O
